Literature DB >> 10891181

Revised constitution of sclerophytins A and B.

D Friedrich1, R W Doskotch, L A Paquette.   

Abstract

[structure: see text] Spectroscopic reevaluation of sclerophytin B, the acetate of sclerophytin A, has demonstrated unequivocally that these coral metabolites are not composed of two ether bridges.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891181     DOI: 10.1021/ol000084g

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  A general route toward the synthesis of the cladiellin skeleton utilizing a SmI2-mediated cyclization.

Authors:  Gary A Molander; Barbara Czakó; David J St Jean
Journal:  J Org Chem       Date:  2006-02-03       Impact factor: 4.354

2.  Total syntheses of (+)-vigulariol and (-)-sclerophytin A.

Authors:  Michael T Crimmins; Christina S Stauffer; Mark C Mans
Journal:  Org Lett       Date:  2011-08-19       Impact factor: 6.005

3.  A unified strategy for enantioselective total synthesis of cladiellin and briarellin diterpenes: total synthesis of briarellins E and F and the putative structure of alcyonin and revision of its structure assignment.

Authors:  Olivier Corminboeuf; Larry E Overman; Lewis D Pennington
Journal:  J Org Chem       Date:  2009-08-07       Impact factor: 4.354

4.  Synthesis and anticancer activity of sclerophytin-inspired hydroisobenzofurans.

Authors:  T David Bateman; Aarti L Joshi; Kwangyul Moon; Elena N Galitovskaya; Meenakshi Upreti; Timothy C Chambers; Matthias C McIntosh
Journal:  Bioorg Med Chem Lett       Date:  2009-10-22       Impact factor: 2.823

5.  Enantioselective synthesis of (-)-sclerophytin A by a stereoconvergent epoxide hydrolysis.

Authors:  Bin Wang; Armando P Ramirez; Justin J Slade; James P Morken
Journal:  J Am Chem Soc       Date:  2010-10-28       Impact factor: 15.419

6.  Cytotoxic and anti-inflammatory eunicellin-based diterpenoids from the soft coral Cladiella krempfi.

Authors:  Chi-Jen Tai; Jui-Hsin Su; Chiung-Yao Huang; Ming-Shyan Huang; Zhi-Hong Wen; Chang-Feng Dai; Jyh-Horng Sheu
Journal:  Mar Drugs       Date:  2013-03-12       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.